definiens: means ( i ) all clinical data or pre -clinical toxicology data generated by or on behalf of Liverco from the Effective Date until termination of the applicable Program Licence(s ) concerning the applicable Product which is the subject of the applicable terminated Progra m Licence(s ) ; ( ii ) any regulatory filings or submissions made by Liverco until termination of the applicable Program Licence(s ) in respect of the applicable Product which is the subject of the applicable terminated Program Licence(s ) and, ( iii ) any Patent Rights filed prior to termination of the applicable Program Licence(s ) by Liverco which would be infringed by the Exploitation of the applicable Product ( which is the subject of the applicable terminated Program Licence(s ) ) to the extent that Exploitation of the same Product would also infringe any of the Patent Rights licensed to Liverco under the terminated Program Licence ; in each case of ( i ) ( ii ) and ( iii ) above to the extent Controlled by Liverco or its Affiliates ( and free from any restriction or encu mbrance ) ; has the meaning set out in Clause 2.2 ; means all AAV manufacturing technologies listed in Schedule 4 ; or means an application for a Marketing Approval ; or means those Regulatory Approval(s ) required by applicable laws and regulations in a particular country or territory in order to sell or commercially supply a medicinal product and/or device in that country or territory ; has the meaning set out in Clause 5.7 ; means Program Materials and Background Materials ; means a Success Milestone ; means a Success Milestone Payment ; has the maning in Part C of Schedul e 8 ; has the meaning in Part A of Schedule 8 ; means any discovery, invention ( whether patentable or not ), Know -How or improvement concerning [ * * ] which ( i ) is of application outside the Excluded Field, and ( ii ) is not an Impro vement and ( iii ) has been discovered, generated, identified or invented by AN ( except in connection with his direction or supervision of the Haemostasis Group unless such work or research is in relation to isolating, characterising and/or developing a ther apeutic product ) and/or by any member(s ) of the AN Laboratory within [ * * ] of the Effective Date, and ( iv ) is Controlled by UCL or UCLB either at the time of 14 Certain confidential information contained in this document, marked by [ * * ], has been om itted because the information ( i ) is not material and ( ii ) would likely cause competitive harm to the Company if publicly disclosed